Search
Crinetics Pharmaceuticals Inc
CRNXAdd to Watchlist
84.950USD
+0.110+0.13%
Close 08-31 16:00（ET）
8.99BMarket Cap
LossP/E TTM
Crinetics Pharmaceuticals Inc (CRNX) Stock Price Target & Forecast
Target Price
84.222USD-0.86%
CRNX Analyst Recommendation Trends
In the current month, CRNX has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CRNX average Analyst price target in the last month is 84.222.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
5
5
5
5
5
5
0
0
10
10
10
10
10
10
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
16
16
16
16
16
CRNX Analyst Rating for Peer Comparison
Updated: Oct 8, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
18
0
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
14
1
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
IQVIA Holdings Inc
IQV
8
11
3
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Financial Forecasting
Based on analysts' estimates, CRNX EPS is projected to reach -1.187 in FY2026Q3, following reported EPS of -1.145 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.37
-1.24
-1.21
-1.19
-1.16
Actual
-1.29
-1.23
-1.14
--
--
Surprise
+5.57%
+0.71%
+5.30%
--
--
FAQs
What is Crinetics Pharmaceuticals Inc's expected revenue for the next quarter?
Crinetics Pharmaceuticals Inc's expected revenue is 18.52M.
What is Crinetics Pharmaceuticals Inc's price target?
Analysts forecast that Crinetics Pharmaceuticals Inc's price target is USD 83.00, with the highest forecast at USD 108.00 and the lowest forecast at USD 45.00.
How have Crinetics Pharmaceuticals IncCRNX's recent earnings per share performed?
The market expectation was USD -1.14, while Crinetics Pharmaceuticals IncCRNX's earnings per share (EPS) for the previous quarter was USD -1.23. EPS for the next quarter is expected at USD -1.19.